The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man.
Joseph M. Vinci(Vinci (United Kingdom)), Harry R. Keiser(National Heart Lung and Blood Institute), Randall M. Zusman(Boston Biomedical Research Institute), David L. Horwitz, John J. Pisano, Kevin Catt(National Institutes of Health)
Cited by 126
Related Papers
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
|Pharmacological Reviews|2000|2.1k
Solid-Phase Radioimmunoassay in Antibody-Coated Tubes
|Science|1967|575
Autoradiographic localization of angiotensin II receptors in rat brain.
|Proceedings of the National Academy of Sciences|1984|569
Angiotensin Receptors and Their Antagonists
|New England Journal of Medicine|1996|560